WAT

Waters Corp
D

WAT

303.04
USD
4.32
(1.44%)
مغلق
حجم التداول
52,515
الربح لكل سهم
13
العائد الربحي
-
P/E
27
حجم السوق
18,033,336,785
أصول ذات صلة
A
A
-0.110
(-0.09%)
120.190 USD
AMGN
AMGN
-2.01
(-0.65%)
306.66 USD
BAX
BAX
0.440
(1.53%)
29.225 USD
BDX
BDX
1.850
(1.01%)
185.410 USD
B
BIO
1.99
(0.76%)
263.91 USD
BSX
BSX
-0.020
(-0.02%)
106.150 USD
DHR
DHR
2.650
(1.31%)
205.510 USD
DXCM
DXCM
2.230
(2.57%)
88.980 USD
EW
EW
4.190
(5.53%)
79.960 USD
HOLX
HOLX
0.370
(0.56%)
66.500 USD
IDXX
IDXX
15.20
(2.76%)
565.38 USD
ILMN
ILMN
1.730
(1.61%)
109.330 USD
LH
LH
-2.48
(-0.93%)
264.80 USD
MTD
MTD
1.66
(0.13%)
1,264.50 USD
المزيد
الأخبار المقالات

العنوان: Waters Corp

القطاع: Healthcare
الصناعة: Diagnostics & Research
Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2024, Waters generated 58% from biopharmaceutical customers, 31% from industrial clients, and 11% from academic/government institutions. In early 2026, Waters plans to merge with BD's life science and diagnostics business, which will substantially change those concentrations. Waters will wind up with more concentration in diagnostics (versus none now) and discovery-related life science tools.